title: Calcium channel blockade inhibits release of TNF alpha and improves survival in a rat model of acute pancreatitis.
abstract: Tumor necrosis factor-alpha (TNF alpha) has been implicated as one of the numerous likely mediators of the systemic complications of acute pancreatitis. Recent suggestions that calcium (Ca2+) acts as a signal not only for TNF alpha release but also for TNF alpha action at distant sites led us to hypothesize that the calcium channel blocker diltiazem could inhibit TNF alpha release in acute pancreatitis, ameliorating the severity of the disease and improving overall survival. A rat model of acute pancreatitis induced by retrograde ductal infusion of bile was used for two experiments (n = 120). Experiment 1 was designed to determine the effects of calcium channel blockade using diltiazem on the severity of pancreatitis as measured by changes in biochemistry, pathology, and serum TNF alpha levels. In experiment 2, effects of calcium channel blockade on animal survival were measured over 72 h. Calcium channel blockade was associated with a significant reduction in serum TNF alpha levels as well as amelioration of pancreatitis by biochemical and pathological criteria. Overall survival from bile-induced pancreatitis was dramatically improved in rats pretreated with diltiazem (80%) compared to untreated animals (40%). Our data suggest that calcium channel blockade is associated with TNF alpha inhibition and improved outcome in a rat model of acute pancreatitis.
authors.affiliation: Department of Surgery, University of Tennessee, Memphis 38163, USA.
authors.forename: C B
authors.initials: CB
authors.lastname: Hughes
authors.forename: A B
authors.initials: AB
authors.lastname: el-Din
authors.forename: M
authors.initials: M
authors.lastname: Kotb
authors.forename: L W
authors.initials: LW
authors.lastname: Gaber
authors.forename: A O
authors.initials: AO
authors.lastname: Gaber
mesh_terms: D000208:Acute Disease; D000818:Animals; D002121:Calcium Channel Blockers / Q000494:pharmacology*; D004110:Diltiazem / Q000494:pharmacology*; D004195:Disease Models, Animal; D010450:Endopeptidases / Q000378:metabolism; D004789:Enzyme Activation / Q000187:drug effects; D007511:Ischemia / Q000517:prevention & control; D008297:Male; D010195:Pancreatitis / Q000188:drug therapy* / Q000503:physiopathology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D013997:Time Factors; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism*
chemical_list: D002121:Calcium Channel Blockers; D014409:Tumor Necrosis Factor-alpha; D010450:Endopeptidases; D004110:Diltiazem